Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

EU-Canada Free Trade Agreement: an Opportunity to Create Manufacturing Jobs in the Generic and Biosimilar Medicines Industries

20 February 2017

Medicines for Europe welcomes the approval by the European Parliament […]

Read more

Biosimilar medicines: Increasing access to modern essential medicines while supporting sustainability of healthcare systems

16 February 2017

Biologic medicines have revolutionised the management of many serious diseases […]

Read more

Health Minister Can Take Action to Increase Patient Access to Biosimilar Medicines in Ireland

8 February 2017

Today, Medicines for Europe engaged alongside its Irish national association […]

Read more

Joint statement on Shortages

2 February 2017

The European associations representing manufacturers of medicinal products, parallel distributors, […]

Read more

European Parliament prioritises Generic, Biosimilar and Value Added Medicines Competition to improve Access

31 January 2017

Today, the Environment, Public Health and Food Safety Committee (ENVI) voted […]

Read more

Building a 21st Century Regulatory Environment for Better Patient Access to Medicines

26 January 2017

This week in London, Medicines for Europe gathers national authorities, […]

Read more

Opportunities that Technology and Social Media Bring to Pharmacovigilance Explored in London this Week

25 January 2017

National authorities, regulators, industry leaders and pharmacists gathered in London […]

Read more

Biosimilar medicines. Essential for increasing access to important medicines and the sustainability of healthcare systems

25 January 2017

Biologic medicines have revolutionised the management of many serious diseases […]

Read more

European Commission Initiative Improves Information for Patients on Biosimilar Medicines

23 January 2017

Today, the European Commission published a unique Q&A for patients […]

Read more

Subscribe to our newsletter